RHY
RHYTHM BIO FPO [RHY]
Healthcare · ASX Small Cap
$0.0850 -1.2%
Updated 22 Jul 2026 · Signals refresh every scan
Get alerts when RHY triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Sitting near support — this level has held before and could attract buyers again
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Critical cash runway (1.1 quarters)
- Revenue in sharp decline (-49%)
- Near 52-week low (15% of range)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -49% — the top line is shrinking
- The bigger volume days are the down days — volume-weighted momentum is negative (-2.48%/day)
Ask Scout AI about RHY
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE New Lung Cancer Genetype Risk Assessment Test
NONE Rhythm launches tailored ColoSTAT marketing campaign
NONE ColoSTAT Access Program Gains Momentum
LOW Accreditation Matters Conference Presentation
LOW Rhythm Bio Singapore Investor Presentation
Announcement tone -5pts
Recent ASX Announcements
| 2026-07-20 | New Lung Cancer Genetype Risk Assessment Test |
| 2026-07-06 | Accreditation Matters Conference Presentation |
| 2026-07-01 | Rhythm launches tailored ColoSTAT marketing campaign |
| 2026-06-03 | Rhythm Bio Singapore Investor Presentation |
| 2026-05-25 | ColoSTAT Access Program Gains Momentum |
Key Metrics
$30.4M
Market Cap
229K
Avg Volume
1.1x
Vol Ratio
$0.05 — $0.28
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-190.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 69% |
| L | Leader vs Laggard | laggard | RS: -22 |
| I | Institutional Sponsorship | weak | Inst: 10% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
101 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track RHY and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required